Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandri, F
Right arrow Articles by Mosca, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandri, F
Right arrow Articles by Mosca, F
Archives of Disease in Childhood Fetal and Neonatal Edition 2004;89:F394-F398
© 2004 Archives of Disease in Childhood Fetal and Neonatal Edition


ORIGINAL ARTICLE

Prophylactic nasal continuous positive airways pressure in newborns of 28–31 weeks gestation: multicentre randomised controlled clinical trial

F Sandri1, G Ancora1, A Lanzoni1, P Tagliabue2, M Colnaghi3, M L Ventura2, M Rinaldi4, I Mondello5, P Gancia6, G P Salvioli1, M Orzalesi7, F Mosca3 on behalf of the Pneumology Study Group of the Italian Society of Neonatology

1 Institute of Neonatology, University of Bologna, Bologna, Italy
2 Division of Neonatology, San Gerardo Hospital, Monza, Italy
3 Department of Neonatology, Clinica Mangiagalli, ICP, Milano, Italy
4 Division of Neonatology, Ospedali Riuniti, Foggia, Italy
5 Division of Neonatology, Bianchi Melacrino Morelli Hospital, Reggio Calabria, Italy
6 Division of Neonatology, Policlinico S Matteo, Pavia, Italy
7 Department of Medical and Surgical Neonatology, Bambino Gesù Children’s Hospital, Rome, Italy

Correspondence to:
Correspondence to:
Dr Sandri
Istituto di Neonatologia, Via Massarenti, 11 40138 Bologna, Italy; sandri{at}med.unibo.it

Background: The role of nasal continuous positive airways pressure (nCPAP) in the management of respiratory distress syndrome in preterm infants is not completely defined.

Objective: To evaluate the benefits and risks of prophylactic nCPAP in infants of 28–31 weeks gestation.

Design: Multicentre randomised controlled clinical trial.

Setting: Seventeen Italian neonatal intensive care units.

Patients: A total of 230 newborns of 28–31 weeks gestation, not intubated in the delivery room and without major malformations, were randomly assigned to prophylactic or rescue nCPAP.

Interventions: Prophylactic nCPAP was started within 30 minutes of birth, irrespective of oxygen requirement and clinical status. Rescue nCPAP was started when FIO2 requirement was > 0.4, for more than 30 minutes, to maintain transcutaneous oxygen saturation between 93% and 96%. Exogenous surfactant was given when FIO2 requirement was > 0.4 in nCPAP in the presence of radiological signs of respiratory distress syndrome.

Main outcome measures: Primary end point: need for exogenous surfactant. Secondary end points: need for mechanical ventilation and incidence of air leaks.

Results: Surfactant was needed by 22.6% in the prophylaxis group and 21.7% in the rescue group. Mechanical ventilation was required by 12.2% in both the prophylaxis and rescue group. The incidence of air leaks was 2.6% in both groups. More than 80% of both groups had received prenatal steroids.

Conclusions: In newborns of 28–31 weeks gestation, there is no greater benefit in giving prophylactic nCPAP than in starting nCPAP when the oxygen requirement increases to a FIO2 > 0.4.


Abbreviations: CPAP, continuous positive airways pressure; FIO2, fraction of inspired oxygen; MV, mechanical ventilation; nCPAP, nasal continuous positive airways pressure; RDS, respiratory distress syndrome; SpO2, transcutaneous oxygen saturation

Keywords: nasal continuous positive airways pressure; prophylaxis; surfactant; respiratory distress syndrome; preterm newborn




This article has been cited by other articles:


Home page
PediatricsHome page
Changing Use of Surfactant Over 6 Years and Its Relationship to Chronic Lung Disease
Pediatrics, October 1, 2008; 122(4): e917 - e921.



Home page
PediatricsHome page
E. Chong, J. Greenspan, S. Kirkby, J. Culhane, and K. Dysart
Changing Use of Surfactant Over 6 Years and Its Relationship to Chronic Lung Disease
Pediatrics, September 29, 2008; (2008) peds.2007-3193v1.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
W. A. Engle and and the Committee on Fetus and Newborn
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Pediatrics, February 1, 2008; 121(2): 419 - 432.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. A. Thomson, B. A. Yoder, V. T. Winter, L. Giavedoni, L. Y. Chang, and J. J. Coalson
Delayed Extubation to Nasal Continuous Positive Airway Pressure in the Immature Baboon Model of Bronchopulmonary Dysplasia: Lung Clinical and Pathological Findings
Pediatrics, November 1, 2006; 118(5): 2038 - 2050.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. N. Finer, W. A. Carlo, S. Duara, E. F. Donovan, and A. A. Fanaroff
Delivery Room Continuous Positive Airway Pressure: Practice and Feasibility: In Reply
Pediatrics, January 1, 2005; 115(1): 198 - 198.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health